FMACUFuture Money Acquisition Corporation

🇺🇸 US
10.13
USD
Analysis Scores
Lothien Robustness Score?
57/100
Strong
Neden bu skor?
Damodaran ?
34/100
DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
100/100
Piotroski ?
N/A
Yetersiz çeyrek verisi: 2 mevcut, en az 5 gerekli
Graham ?
-
Yetersiz çeyrek verisi: 2 mevcut, en az 4 gerekli
Active Metric?
2/4
Confidence?
56%
Lothien Robustness Summary
63/100
Lothien Sağlamlık: Güçlü (63/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 6 | Negatif: 3 | Nötr: 0
Net Kâr Pozitif
Son çeyrekte $290,108 net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+728.3 arttı (-$46,172 → $290,108). Kısa vadede olumlu momentum.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından $150,500 fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 37.47x — kısa vadeli borçları rahat karşılıyor.
Borç Azalıyor
Toplam borç çeyreklik %-99.8 düştü. Bilanço güçleniyor.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif ($290,108) ama FCF negatif (-$87,429). Yatırım harcamaları yüksek veya alacak birikimi var.
Yüksek F/K Uyarısı
Trailing F/K: 100.0. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Özkaynak Büyümesi
Özkaynak çeyreklik %+160614.4 arttı. Şirket içsel birikimle güçleniyor.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-38.6 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-09-25 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-09-25
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Düşük
157 days
Annual Volatility ?
%2.9
VaR 95% ?
%0.29
daily max loss
VaR 99% ?
%0.41
daily max loss
CVaR 95% ?
%0.44
expected loss (tail)
Max Drawdown ?
%1.7
13.08.2026 → 10.11.2026
Skewness ?
0.72
Parametrik%0.29
Historik%0.20
Cornish-Fisher%0.17
Return Distribution
Valuation
Potential?
+15.6%
ROIC ?
-0.1%
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Fiyat TRAMA-99 hafif altında: %-1.7
Direnç seviyesi: TRAMA-99 = 10.31 USD
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %0.5
ROE %0.5 — low return on equity.
Valuation
P/E Ratio 100.0x Sector: 58.7x
F/K 100.0x — sector median's (58.7x) %70 above. Expensive zone.
P/B Ratio 1.44x Sector: 3.63x
PD/DD 1.44x — sector median's (3.63x) well below. Cheap relative to book value.
Indebtedness
Current Ratio 37.47x
Current ratio 37.47x — current assets are 2x short-term liabilities. Very healthy liquidity.
Debt / Equity 0.00x
Low leverage — majority of assets financed by equity.
Growth
No balance sheet data
Score Explanations
Lothien Robustness
57/100
Good robustness (57/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+15.6%
Plus %15.6 expected value (11.92) vs current price comparison. 2/4 valuation models could be calculated. Model confidence %56.
Components: PE target: 2.58 | P/B target: 25.93
Damodaran Valuation
34/100
Weak
Dalio Risk Analysis
100/100
Low debt risk (100/100).
Leverage: 100/100 | Debt Service: 100/100 | Quality: 50/100
ROIC - Return on Capital
%-0.1
ROIC (%-0.1) cost of capital (13.8%) below → destroying value.
WACC: %13.8
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
100.0x vs 58.7x
Sector median's %70 above — expensive
P/B Ratio
1.44x vs 3.63x
Compared to sector %60 cheaper (by book value)
ROIC vs WACC
%-0.1 vs %13.8 WACC
ROIC 13.9 bps below cost of capital
↔
TRAMA-99 Trend — Near TRAMA
Price (10.13), TRAMA-99 line (10.31) at close levels (%-1.7). Important decision zone — breakout direction will determine the trend.
Price:: 10.13
TRAMA: 10.31
Difference: %-1.7
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

FMACU — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.